Showing 41401 - 41425 of 46114 for "" with applied filters
Capital markets, M&A
Capital markets, M&A, Private equity, Real estate finance
Banking, Capital markets : Derivatives, Financial restructuring
Banking, Capital markets, Financial services regulatory
Capital markets, M&A, Private equity
Financial services regulatory, M&A
Asset finance, Financial services regulatory
Banking, Capital markets : Debt
Capital markets : Equity, M&A
M&A, Private equity
M&A
Capital markets : Debt
M&A
09 July 2015 by Benedikt Maurenbrecher, Dieter Grünblatt and Stefan Kramer
Benedikt Maurenbrecher, Dieter Grünblatt and Stefan Kramer of Homburger discuss the Swiss taxation system’s impact on the issuance of covered bonds at an international level
05 October 2020 by Homburger
Homburger advised Zürcher Kantonalbank in the issuance of CHF 275,000,000 1.75% AT1 Write-Down Notes
26 February 2019 by Homburger
Daniel Haeberli and Benjamin Leisinger, partners at Homburger, look at how the cryptoasset class has been thrown open to institutional investors
Banking and finance, Capital markets, Restructuring and insolvency
M&A, Private equity
Capital markets, M&A
M&A
06 October 2020 by Homburger
Homburger advised Dufry on the strategic joint venture with Alibaba Group and its CHF 250 m equity investment commitment in the context of the planned CHF 700 m rights offering
29 October 2020 by Homburger
On October 28, 2020, Molecular Partners AG (SIX: MOLN) (Molecular Partners), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin
11 October 2020 by Homburger
On October 5, 2020, Avaloq Group (Avaloq), a Swiss-based global leader in digital banking solutions, core banking software and wealth management technology, announced that...
19 October 2020 by Homburger
On October 15, 2020, VectivBio AG, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, announced that...
15 October 2020 by Homburger
Homburger has advised Siegfried on the acquisition of two Novartis manufacturing sites in Spain